Navigation Links
Summer Street Research Announces Expansion of Research Team with the Addition of Ling Wang, CFA, Senior Biotechnology Analyst
Date:7/14/2011

BOSTON, July 14, 2011 /PRNewswire/ -- Summer Street Research Partners announced today that Ling Wang, CFA, has joined the firm as senior biotechnology analyst, director. She will be focused on covering the biotechnology sector, continuing to build out the biotechnology sector for the firm. Ms. Wang joins the firm with years of equity research experience.  

"We are very excited to welcome Ling to the research team at Summer Street. Ling is a proven analyst with extensive Wall Street experience," says Dr. Mark Landy, director of research for Summer Street Research. "We believe Ling will bring valuable insights and a unique perspective to our research product, which will benefit our clients."

Prior to joining Summer Street, Ms. Wang was a senior vice president and senior biotechnology analyst at Brean Murray, Carret & Co. since 2009. Prior to Brean Murray, she was a research associate covering biotechnology stocks at Rodman & Renshaw from 2006 to 2008. Prior to that, she was a research assistant in the life science group at Manning & Napier Advisors, Inc. (an investment firm with approximately $16 billion assets under management) from 2004 to 2006. Ms. Wang earned her undergraduate degree in biology from Beijing University. She also holds a master's degree in molecular pharmacology from Albert Einstein College of Medicine and an MBA degree in finance from Yale University.

"I'm very excited to join Summer Street," Ms. Wang says. "With their unique MCRI consulting network and their singular focus on the healthcare sector, I believe Summer Street is the right platform for me to add real value to institutional healthcare investors on important and timely topics."  

About Summer Street Research, Inc.

Summer Street Research Partners is an investment banking, institutional equity research and trading firm that focuses exclusively on the healthcare sector. Our mission is to help our clients maximize returns by providing the best healthcare research, ideas and investment opportunities. The firm was founded in 2002, with a culture of providing a proprietary equity research, utilizing more than 10,000 physicians and industry professionals provided through MCRI, a division of Summer Street Research Partners.  www.ssrp.com

Media Contact:
Cyrus Alphonse
617-532-6464


'/>"/>
SOURCE Summer Street Research Partners
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Summer Street Research Partners Closes Financing for ImmunoCellular Therapeutics, Ltd.
2. Expanded Lipoprotein Testing, VAPĀ® Cholesterol Test Discussed at National Lipid Association Summer Clinical Lipid Update
3. Cellectis to Present at the FASEB Summer Research Conference on Genome Engineering
4. Health Robotics and McKesson to Showcase i.v.STATION and i.v.SOFT at ASHPs Summer Meeting, Tampa, June 6-8, 2010
5. Summerhill Biomass Systems Unveils Solid Biomass Technology System at Syracuse Expo
6. ECBC Now Accepting Applications for 2009 Minority Undergraduate Summer Internship Program
7. LI-COR Updates Product and Application Guide for Summer 2008
8. Veteran Wall Street Securities Analyst Reports on Health Discovery Corporation
9. Scott Garrett Joins Water Street Healthcare Partners
10. NeoStem to Present at Wall Street Forum 2011 Financial Conference on Tuesday, March 1
11. Aethlon Medical to Present at the Wall Street Analyst Forum 22nd Annual Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Durham, NC (PRWEB) , ... June 23, 2016 , ... ... Odense University Hospital in Denmark detail how a patient who developed lymphedema after being ... (fat) tissue. The results could change the paradigm for dealing with this debilitating, frequent ...
(Date:6/23/2016)... June 23, 2016  Blueprint Bio, a company dedicated ... the medical community, has closed its Series A funding ... . "We have received a commitment from ... we need to meet our current goals," stated ... the runway to complete validation on the current projects ...
(Date:6/23/2016)... June 23, 2016 On Wednesday, June ... 4,833.32, down 0.22%; the Dow Jones Industrial Average edged 0.27% ... at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the ... Nektar Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. ... BIND ). Learn more about these stocks by ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance ... consulting, provides a free webinar on Performing Quality Investigations: Getting to ... 12pm CT at no charge. , Incomplete investigations are still a major concern ...
Breaking Biology Technology:
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
Breaking Biology News(10 mins):